AU664237B2 - {(benzodioxan, benzofuran or benzopyran)-alkylamino} alkyl substituted guanidines as selective vascoconstrictors - Google Patents

{(benzodioxan, benzofuran or benzopyran)-alkylamino} alkyl substituted guanidines as selective vascoconstrictors Download PDF

Info

Publication number
AU664237B2
AU664237B2 AU34991/93A AU3499193A AU664237B2 AU 664237 B2 AU664237 B2 AU 664237B2 AU 34991/93 A AU34991/93 A AU 34991/93A AU 3499193 A AU3499193 A AU 3499193A AU 664237 B2 AU664237 B2 AU 664237B2
Authority
AU
Australia
Prior art keywords
formula
hydrogen
alk
amino
benzopyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU34991/93A
Other languages
English (en)
Other versions
AU3499193A (en
Inventor
Marcel Frans Leopold De Bruyn
Walter Jacobus Joseph Janssens
Guy Rosalia Eugene Van Lommen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU3499193A publication Critical patent/AU3499193A/en
Application granted granted Critical
Publication of AU664237B2 publication Critical patent/AU664237B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26—Separation; Purification; Stabilisation; Use of additives
    • C07C319/28—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
AU34991/93A 1992-02-27 1993-02-19 {(benzodioxan, benzofuran or benzopyran)-alkylamino} alkyl substituted guanidines as selective vascoconstrictors Expired AU664237B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84256092A 1992-02-27 1992-02-27
US842560 1992-02-27
PCT/EP1993/000435 WO1993017017A1 (en) 1992-02-27 1993-02-19 [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors

Publications (2)

Publication Number Publication Date
AU3499193A AU3499193A (en) 1993-09-13
AU664237B2 true AU664237B2 (en) 1995-11-09

Family

ID=25287639

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34991/93A Expired AU664237B2 (en) 1992-02-27 1993-02-19 {(benzodioxan, benzofuran or benzopyran)-alkylamino} alkyl substituted guanidines as selective vascoconstrictors

Country Status (37)

Country Link
US (4) US5541180A (enExample)
EP (1) EP0639192B1 (enExample)
JP (1) JP2779268B2 (enExample)
KR (1) KR100190300B1 (enExample)
CN (1) CN1038032C (enExample)
AP (1) AP416A (enExample)
AT (1) ATE138064T1 (enExample)
AU (1) AU664237B2 (enExample)
BG (1) BG62052B1 (enExample)
CA (1) CA2117483C (enExample)
CZ (1) CZ282092B6 (enExample)
DE (1) DE69302687T2 (enExample)
DK (1) DK0639192T3 (enExample)
EE (1) EE03029B1 (enExample)
ES (1) ES2087721T3 (enExample)
FI (1) FI109122B (enExample)
GR (1) GR3019927T3 (enExample)
HR (1) HRP930235B1 (enExample)
HU (2) HU222495B1 (enExample)
IL (1) IL104868A (enExample)
LT (1) LT3049B (enExample)
LV (1) LV10715B (enExample)
MX (1) MX9301053A (enExample)
MY (1) MY110627A (enExample)
NO (1) NO306255B1 (enExample)
NZ (1) NZ249124A (enExample)
OA (1) OA10095A (enExample)
PH (1) PH31295A (enExample)
PL (1) PL174736B1 (enExample)
RO (1) RO115630B1 (enExample)
RU (1) RU2121999C1 (enExample)
SG (1) SG47763A1 (enExample)
SI (1) SI9300097B (enExample)
SK (1) SK280166B6 (enExample)
TW (1) TW225531B (enExample)
WO (1) WO1993017017A1 (enExample)
ZA (1) ZA931404B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282108B6 (sk) * 1993-08-19 2001-11-06 Janssen Pharmaceutica N. V. Substituované dihydropyranopyridíny, spôsob a medziprodukty na ich výrobu a farmaceutické prostriedky na ich báze
ATE256130T1 (de) * 1993-08-19 2003-12-15 Janssen Pharmaceutica Nv Gefässverengende dihydrobenzopyranderivate
PH31437A (en) * 1993-08-27 1998-11-03 Janssen Pharmaceutica Nv Tontophoretic delivery of an antimigrane drug.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
US6054462A (en) * 1994-04-13 2000-04-25 Janssen Pharmaceutica, N.V. Intranasal antimigraine compositions
HRP950149A2 (en) * 1994-04-13 1997-06-30 Janssen Pharmaceutica Nv Intranasal antimigrene composition
FR2724383B1 (fr) * 1994-09-13 1996-10-18 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
ES2169102T3 (es) * 1994-10-14 2002-07-01 Merck Patent Gmbh (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central.
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
KR19990021931A (ko) * 1995-06-08 1999-03-25 디르크 반테 미세구형 전분의 항편두통 조성물
FR2752735B1 (fr) * 1996-09-05 1998-10-02 Synthelabo Utilisation de derives de benzofurane pour obtenir un medicament destine au traitement de l'insuffisance veineuse et de l'ulcere veineux
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
RU2134108C1 (ru) * 1998-10-06 1999-08-10 Заславская Рина Михайловна Средство для лечения артериальной гипертонии, способ лечения артериальной гипертонии
FR2787789B1 (fr) * 1998-12-29 2002-06-14 Lipha Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
KR100702526B1 (ko) * 1999-06-02 2007-04-04 얀센 파마슈티카 엔.브이. 피롤리디닐, 피페리디닐 또는 호모피페리디닐 치환된(벤조디옥산, 벤조푸란 또는 벤조피란) 유도체
UA73122C2 (en) * 1999-06-02 2005-06-15 Janssen Pharmaceutica Nv Derivatives of benzodioxane, benzofuran or benzopyran substituted by aminoalkyl
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
WO2002044159A2 (en) * 2000-11-29 2002-06-06 Eli Lilly And Company 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
MXPA03007621A (es) * 2001-02-23 2003-12-04 Merck & Co Inc Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
ATE352302T1 (de) 2001-07-26 2007-02-15 Merck Patent Gmbh Verwendung von 2- 5-(4-fluorphenyl)-3- pyridylmethylaminomethyl-chroman und seiner physiologisch annehmbaren salze
DE60211186T2 (de) * 2001-09-19 2007-01-18 Merck Patent Gmbh Neue verwendung substituierter aminomethylchromane
EP1594558A1 (en) * 2003-01-31 2005-11-16 Zimmer Orthobiologics, Inc. Hydrogel compositions comprising nucleus pulposus tissue
ZA200507112B (en) * 2003-03-31 2007-03-28 Taisho Pharmaceutical Co Ltd Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
CN105061392B (zh) * 2015-07-20 2017-07-18 上海现代哈森(商丘)药业有限公司 一种硫酸胍生合成方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
AU5314894A (en) * 1993-02-09 1994-08-11 Bayer Aktiengesellschaft Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
NL296841A (enExample) * 1962-08-20
FR1366472A (fr) * 1962-09-29 1964-07-10 Glaverbel Dispositif pour la fabrication du verre en feuille
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GR71865B (enExample) * 1978-03-20 1983-07-07 Ciba Geigy
US4405922A (en) * 1979-05-23 1983-09-20 Hitachi Koki Company, Limited Failure detection circuit for impact printers or the like
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
CA2011899A1 (en) * 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
WO1994017017A1 (en) * 1991-07-15 1994-08-04 Exxon Research And Engineering Company Benzene removal from gasoline boiling range streams

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405622A (en) * 1980-10-16 1983-09-20 Syntex (U.S.A.) Inc. [1-(1,4-Benzodioxan-2-yl)-4-(4-aminopyrimidin-2-yl]piperazines useful as anti-depressants
AU5314894A (en) * 1993-02-09 1994-08-11 Bayer Aktiengesellschaft Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid

Also Published As

Publication number Publication date
IL104868A (en) 1998-01-04
BG62052B1 (bg) 1999-01-29
MX9301053A (es) 1994-03-31
EE03029B1 (et) 1997-08-15
EP0639192A1 (en) 1995-02-22
HU211742A9 (en) 1995-12-28
OA10095A (en) 1996-12-18
PH31295A (en) 1998-07-06
NZ249124A (en) 1995-08-28
SI9300097A (en) 1993-09-30
BG98870A (bg) 1995-03-31
SG47763A1 (en) 1998-04-17
KR100190300B1 (ko) 1999-06-01
LTIP367A (lt) 1994-04-25
CN1079470A (zh) 1993-12-15
WO1993017017A1 (en) 1993-09-02
IL104868A0 (en) 1993-06-10
DK0639192T3 (da) 1996-08-19
LV10715A (lv) 1995-06-20
GR3019927T3 (en) 1996-08-31
HU222495B1 (hu) 2003-07-28
ATE138064T1 (de) 1996-06-15
MY110627A (en) 1998-09-30
NO943186D0 (no) 1994-08-29
US5607949A (en) 1997-03-04
HUT71129A (en) 1995-11-28
CA2117483A1 (en) 1993-09-02
RU94041210A (ru) 1996-07-10
EP0639192B1 (en) 1996-05-15
SK102994A3 (en) 1995-07-11
AP9300493A0 (en) 1993-04-30
JPH07504408A (ja) 1995-05-18
CA2117483C (en) 2001-01-09
AP416A (en) 1995-09-29
HRP930235A2 (en) 1997-10-31
AU3499193A (en) 1993-09-13
TW225531B (enExample) 1994-06-21
PL174736B1 (pl) 1998-09-30
ZA931404B (en) 1994-08-26
LV10715B (en) 1995-12-20
DE69302687T2 (de) 1996-11-14
JP2779268B2 (ja) 1998-07-23
HRP930235B1 (en) 1999-04-30
US5624952A (en) 1997-04-29
HU9402464D0 (en) 1994-10-28
RO115630B1 (ro) 2000-04-28
US5541180A (en) 1996-07-30
LT3049B (en) 1994-10-25
FI109122B (fi) 2002-05-31
CS202094A3 (en) 1995-01-18
ES2087721T3 (es) 1996-07-16
SI9300097B (en) 2001-12-31
SK280166B6 (sk) 1999-09-10
DE69302687D1 (de) 1996-06-20
NO306255B1 (no) 1999-10-11
NO943186L (no) 1994-08-29
CZ282092B6 (cs) 1997-05-14
FI943928A7 (fi) 1994-08-26
US5688952A (en) 1997-11-18
CN1038032C (zh) 1998-04-15
FI943928A0 (fi) 1994-08-26
RU2121999C1 (ru) 1998-11-20

Similar Documents

Publication Publication Date Title
CA2117483C (en) [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors
AU677428B2 (en) Vasoconstrictive dihydrobenzopyran derivatives
CA2168023C (en) Vasoconstrictive substituted aryloxyalkyl diamines
EP0808316B1 (en) Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
CA2168022C (en) Vasoconstrictive substituted dihydropyranopyridines
US5703115A (en) (benzodioxan, benzofuran or benzopyran) alkylamino! alkyl substituted guanidines
CA2211889C (en) Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines